McMaster University scientists have found that an anticonvulsant drug may help in developing a new class of antibiotics. Although dozens of antibiotics target what bacteria do, their study has looked at how a certain part of bacteria are created, and they found there is a way of stopping it.
The discovery is important as there is growing concern worldwide about how antibiotic resistance is making the cures for infections ineffective. The World Health Organization has declared that antibiotic resistance is a major threat to global health security.
The McMaster study found that an anticonvulsant drug called lamotrigine is the first chemical inhibitor of the assembly of ribosomes in bacteria. Ribosomes are the molecular machines in cells that create all proteins. Many antibiotics attack what ribosomes do. However, the McMaster team found that lamotrigine stopped ribosomes from being created in the first place.
The paper has been published by the open-access journal eLife.
"Ribosome-inhibiting antibiotics have been routinely used for more than 50 years to treat bacterial infections, but inhibitors of bacterial ribosome assembly have waited to be discovered," saya Eric Brown, principal investigator of the study and a professor of biochemistry and biomedical sciences at McMaster's Michael G. DeGroote Institute for Infectious Disease Research. "Such molecules would be an entirely new class of antibiotics, which would get around antibiotic resistance of many bacteria. We found lamotrigine works."
Jonathan Stokes, a PhD student who worked on the paper, added that the team was able to identify the precise target for the lamotrigine within the bacteria, allowing the researchers to be clear in their understanding of ribosome assembly and the therapeutic applications of these types of chemicals.
The team used high throughput screening technologies of the Centre for Microbial Chemical Biology at McMaster to make the discovery. The study was funded by the Canadian Institutes of Health Research, the Michael G. DeGroote Institute for Infectious Disease Research, and the Natural Sciences and Engineering Research Council.
Source: McMaster University
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.
Broadening the Path: Diverse Educational Routes Into Infection Prevention Careers
July 4th 2025Once dominated by nurses, infection prevention now welcomes professionals from public health, lab science, and respiratory therapy—each bringing unique expertise that strengthens patient safety and IPC programs.
How Contaminated Is Your Stretcher? The Hidden Risks on Hospital Wheels
July 3rd 2025Despite routine disinfection, hospital surfaces, such as stretchers, remain reservoirs for harmful microbes, according to several recent studies. From high-touch areas to damaged mattresses and the effectiveness of antimicrobial coatings, researchers continue to uncover persistent risks in environmental hygiene, highlighting the critical need for innovative, continuous disinfection strategies in health care settings.